Read the description of severe symptoms in section 4 of this leaflet“Contact your doctor immediately if you experience any of the following symptoms after taking this medicine as they may be serious”
Muscle weakness, sensitivity, or pain, especially if you feel unwell or have a fever, could be due to an abnormal breakdown of muscle fibers that may lead to kidney problems and put your life at risk. You may also experience urine discoloration, and changes in blood test results (significant increase in creatine phosphokinase in blood). If you experience any of these signs or symptoms, please contact your doctor immediately.
Use of Neurontin with other medicines
Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medicine. Especially, inform your doctor (or pharmacist) if you are taking or have taken recently any medicine for seizures, sleep disorders, depression, anxiety, or any other neurological or psychiatric problem.
Medicines containing opioids such as morphine
If you are taking any medicine containing opioids (such as morphine), inform your doctor or pharmacist as opioids may increase the effect of Neurontin. Additionally, the combination of Neurontin with opioids may cause drowsiness, sedation, decreased breathing, or death.
Antacids for indigestion
If you take Neurontin at the same time as antacids containing aluminum and magnesium, the absorption of Neurontin in the stomach may be reduced. It is recommended that Neurontin be taken at least two hours after taking an antacid.
Neurontin
- it is not expected to interact with other antiepileptic medicines or with the oral contraceptive pill.
- it may interfere with some laboratory tests, so if you need a urine test, inform your doctor or the hospital about what you are taking.
Taking Neurontin with food
Neurontin can be taken with or without food.
Pregnancy, breastfeeding, and fertility
Pregnancy
Neurontin can be used during the first trimester of pregnancy if necessary.
If you plan to become pregnant or are pregnant or think you may be pregnant, consult your doctor immediately.
If you become pregnant and have epilepsy, it is essential not to stop taking your medicine without consulting your doctor first, as this may worsen your condition. Stopping your treatment may put both you and your unborn baby at risk.
In a study reviewing data from women in Nordic countries who took gabapentin in the first 3 months of pregnancy, there was no increased risk of birth defects or problems with brain development (neurodevelopmental disorders). However, babies of women who took gabapentin during pregnancy had a higher risk of low birth weight and premature birth.
Contact your doctor immediately if you become pregnant, think you may be pregnant, or plan to become pregnant while taking Neurontin. Do not stop taking this medicine abruptly as this may cause an anticipation of seizures, which could have serious consequences for both you and your baby.
Breastfeeding
Gabapentin, the active ingredient in Neurontin, passes into breast milk. It is not recommended to breastfeed while taking Neurontin, as the effect on the baby is unknown.
Fertility
No effects on fertility have been observed in animal studies.
Driving and operating machinery
Neurontin may cause dizziness, drowsiness, and fatigue. Do not drive, operate heavy machinery, or engage in other potentially hazardous activities until you know if this medicine affects your ability to perform other tasks.
Neurontin contains lactose
Neurontin hard capsules contain lactose (a type of sugar). If your doctor has told you that you have a intolerance to certain sugars, consult with them before taking this medicine.
Neurontin contains sodium
This medicine contains less than 23 mg of sodium (1 mmol) per capsule; it is essentially "sodium-free".
Follow exactly the administration instructions of this medication as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.Do not take a quantity of medication higher than the prescribed one.
Your doctor will determine what dose is suitable for you.
Epilepsy, the recommended dose is
Adults and adolescents
Take the number of capsules as indicated by your doctor. Normally, your doctor will gradually increase your dose. The initial dose will generally be from 300 to 900 mg per day. From there, the dose can be increased, as indicated by your doctor, up to a maximum dose of 3,600 mg per day, divided into three equal doses, for example, one in the morning, one at noon, and one at night.
Children 6 years or older
Your doctor will decide on the dose to be administered to your child based on the child's weight.The treatment will begin with a low initial dose, which will be gradually increased over a period of approximately 3 days. The normal dose for controlling epilepsy is 25-35 mg per kg per day. The dose is normally administered by ingesting the capsules, divided into 3 equal doses per day, normally, one in the morning, one at noon, and one at night.
Neurontin is not recommended for use in children under 6 years of age.
Peripheral neuropathic pain, the recommended dose is
Adults
Take the number of capsules as indicated by your doctor. Normally, your doctor will gradually increase your dose. The initial dose will generally be from 300 to 900 mg per day. From there, the dose can be increased, as indicated by your doctor, up to a maximum dose of 3,600 mg per day, divided into three equal doses, for example, one in the morning, one at noon, and one at night.
If you have kidney problems or if you are receiving hemodialysis treatment
Your doctor may prescribe a different dosing regimen and/or dose if you have kidney problems or if you are receiving hemodialysis treatment.
If you are an elderly patient (over 65 years of age)
You should take the normal dose of Neurontin, except if you have kidney problems.Your doctor may prescribe a different dosing regimen or dose if you have kidney problems.
If you consider that the effect of Neurontin is too strong or too weak, inform your doctor or pharmacist as soon as possible.
Administration method
Neurontin is administered orally.Swallow the capsules whole with a sufficient amount of water.
Continue taking Neurontin until your doctor tells you to stop.
If you take more Neurontin than you should
Doses higher than recommended may cause an increase in adverse effects, including loss of consciousness, dizziness, double vision, slurred speech, numbness, and diarrhea. In case of overdose or accidental ingestion, consult your doctor, pharmacist, or call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount ingested, or go to the emergency unit of the nearest hospital if you take more Neurontin than your doctor prescribed.Bring with you any capsules that you have not taken, along with the packaging and the leaflet so that the hospital can easily identify the medication you have taken.
If you forget to take Neurontin
If you forget to take a dose, take it as soon as you remember, unless it is time for the next dose.Do not take a double dose to compensate for the missed doses.
If you interrupt the treatment with Neurontin
Do not stop taking Neurontin suddenly. If you want to stop taking Neurontin, talk to your doctor first. Your doctor will indicate how to proceed.If you are going to stop treatment, this should be done gradually over a minimum of one week.You should know that you may experience certain adverse effects, called withdrawal syndrome, after interrupting a short or long-term treatment with Neurontin. These include seizures, anxiety, difficulty sleeping, feeling of discomfort (nausea), pain, sweating, tremors, headache, depression, abnormal sensation, dizziness, and general feeling of discomfort. These effects usually occur within the first 48 hours after stopping treatment with Neurontin. If you experience this withdrawal syndrome, contact your doctor.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Contact your doctor immediately if you experience any of the following symptoms after taking this medicine, as they may be serious:
Contact your doctor immediately if you have any of the following symptoms:
• skin rash and redness and/or hair loss
• urticaria
• fever
• persistent swelling of the glands
• swelling of the lips, face, and tongue
• yellowing of the skin or white of the eyes
• unusual bleeding or bruising
• severe fatigue or weakness
• unexpected muscle pain
• frequent infections
These symptoms may be the first signs of a severe reaction. You should have a doctor examine you to decide if you should continue taking Neurontin.
Other side effects include:
Very common: (may affect more than 1 in 10 people)
Common: (may affect up to 1 in 10 people)
Additionally, in clinical trials in children, aggressive behavior and spasmodic movements were reported as frequent side effects..
Uncommon: (may affect up to 1 in 100 people)
Rare: (may affect up to 1 in 1,000 people)
After the commercialization of Neurontin, the following side effects have been reported:
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Vigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keepthis medicationout of sightandout of reach of children.
Do not usethis medicationafter the expiration date that appears on the packaging. The expiration date is the last day of the month indicated.
Do not store at a temperature above30°C.
Medicines should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE collection pointat the pharmacy.Please ask your pharmacist how to dispose of packaging and medicationsyouno longer need.This will help protect the environment.
The active ingredient is gabapentin. Each hard gelatin capsule contains 300 mg of gabapentin.
The other components of Neurontin 300 mg hard capsules are:
Capsule content: lactose monohydrate, cornstarch and talc.
Capsule coating: gelatin, purified water and sodium lauryl sulfate.
The 300 mg hard capsules contain the colorants E171 (titanium dioxide) and E172 (yellow iron oxide). The printing ink used on all hard capsules contains shellac, E171 (titanium dioxide) and E132 (indigocarmine, aluminum salt).
Appearance of the product and contents of the package
The 300 mg capsules are yellow hard capsules printed with “Neurontin 300 mg” and “VLE”.
Available in PVC/PVDC/aluminum blisters included in packs of 20, 30, 50, 60, 84, 90, 98, 100, 200, 500 and 1,000 capsules.
Only some package sizes may be marketed.
Marketing authorization holder and responsible manufacturer
Marketing authorization holder
Viatris Healthcare Limited
Damastown Industrial Park
Mulhuddart, Dublin 15
Dublin
Ireland
Responsible manufacturer
Pfizer Manufacturing Deutschland GmbH
Mooswaldallee 1
79108 Freiburg im Breisgau
Germany
or
MEDIS INTERNATIONAL a.s., production plant Bolatice
Prumyslová 961/16
747 23 Bolatice
Czech Republic
You can request more information about this medicine by contacting the local representative of the marketing authorization holder
Viatris Pharmaceuticals, S.L.U.
Calle General Aranaz, 86
28027 Madrid
Spain
This medicine is authorized in the member states of the European Economic Area and in the United Kingdom (Northern Ireland) with the following name: Neurontin
Member state name | Medicine name |
Austria | Neurontin 300 mg – Hard capsules, Neurontin 400 mg – Hard capsules |
Belgium/Luxembourg | Neurontin 100 mg gelules/harde capsules/ Hartkapseln, Neurontin 300 mg gelules/harde capsules/ Hartkapseln, Neurontin 400 mg gelules/harde capsules/ Hartkapseln |
Cyprus | Neurontin 300 mg hard capsule, Neurontin 400 mg hard capsule |
Czech Republic | Neurontin 100 mg, Neurontin 300 mg, Neurontin 400 mg |
Denmark | Neurontin |
Estonia | Neurontin |
Finland | Neurontin 300 mg kapseli, kova, Neurontin 400 mg kapseli, kova |
France | Neurontin 100 mg gélule, Neurontin 300 mg gélule, Neurontin 400 mg gélule, |
Germany | Neurontin 100 mg Hartkapseln, Neurontin 300 mg Hartkapseln, Neurontin 400 mg Hartkapseln |
Greece | Neurontin 300 mg hard capsule, Neurontin 400 mg hard capsule |
Hungary | Neurontin 100 mg kemény kapszula, Neurontin 300 mg kemény kapszula, Neurontin 400 mg kemény kapszula |
Iceland | Neurontin |
Ireland | Neurontin 100 mg hard capsules, Neurontin 300mg hard capsules, Neurontin 400mg hard capsules |
Italy | Neurontin 100 mg Capsule Rigide, Neurontin 300 mg Capsule Rigide, Neurontin 400 mg Capsule Rigide |
Latvia | Neurontin 100 mg cietas kapsulas, Neurontin 300 mg cietas kapsulas, Neurontin 400 mg cietas kapsulas |
Netherlands | Neurontin 100, harde Capsules 100 mg, Neurontin 300, harde Capsules 300 mg, Neurontin 400, harde Capsules 400 mg |
Norway | Neurontin 100 mg kapsler, harde, Neurontin 300 mg kapsler, harde, Neurontin 400 mg kapsler, harde |
Poland | Neurontin 100, Neurontin 300, Neurontin 400 |
Portugal | Neurontin |
Slovenia | Neurontin 100 mg trde kapsule, Neurontin 300 mg trde kapsule, Neurontin 400 mg trde kapsule |
Spain | Neurontin 300 mg cápsulas duras, Neurontin 400 mg cápsulas duras |
Sweden | Neurontin |
United Kingdom (Northern Ireland) | Neurontin 100 mg Hard Capsules, Neurontin 300 mg Hard Capsules, Neurontin 400 mg Hard Capsules |
Last review date of this leaflet: July 2023
The detailed and updated information about this medicine is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.